Differential Activation of Smads in HeLa and SiHa Cells That Differ in Their Response to Transforming Growth Factor-β

This publication has 43 references indexed in Scilit:

• The p38 MAPK inhibitor, PD169316, inhibits transforming growth factor β-induced Smad signaling in human ovarian cancer cells
  Biochemical and Biophysical Research Communications, 2003
• Loss of expression, and mutations of Smad 2 and Smad 4 in human cervical cancer
  Oncogene, 2003
• Calcium Induces Cell Survival and Proliferation through the Activation of the MAPK Pathway in a Human Hormone-dependent Leukemia Cell Line, TF-1
  Journal of Biological Chemistry, 2003
• Aberrant expression of Smad4 results in resistance against the growth‐inhibitory effect of transforming growth factor‐β in the SiHa human cervical carcinoma cell line
  International Journal of Cancer, 2001
• The TGFβ Receptor Activation Process
  Molecular Cell, 2001
• TGFβ1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation
  Oncogene, 2000
• Transforming Growth Factor-β1-induced Activation of the ERK Pathway/Activator Protein-1 in Human Lung Fibroblasts Requires the Autocrine Induction of Basic Fibroblast Growth Factor
  Published by Elsevier ,2000
• Lack of responsiveness to TGF-β1 in a thyroid carcinoma cell line with functional type I and type II TGF-β receptors and Smad proteins, suggests a novel mechanism for TGF-β insensitivity in carcinoma cells
  Molecular and Cellular Endocrinology, 1999
• Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis
  Oncogene, 1999
• Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
  Proceedings of the National Academy of Sciences, 1979